1042: Early Norepinephrine Use in Septic Shock is Associated with Reduced Mortality
Show notes at pharmacyjoe.com/episode1042. In this episode, I’ll discuss early vs delayed norepinephrine use in patients with septic shock. The…
ATOPP 2025: Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC, FAPO, Highlights Must-See Sessions
Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC, FAPO, discusses the value of the 2025 ATOPP Summit in advancing oncology pharmacy…
Obesity-Linked Exosomes May Drive Tumor Aggressiveness in Triple-Negative Breast Cancer
Obesity and high-fat diets enhance the aggressiveness of triple-negative breast cancer through exosome-mediated mechanisms, revealing new therapeutic targets.
Zanubrutinib Linked to Lower Infection Risk Than Venetoclax Plus Obinutuzumab in Real-World CLL/SLL Study
New research highlights the lower infection risk with zanubrutinib compared to venetoclax in CLL/SLL treatment, offering safer options for patients.
Research Suggests Vitamin D Deficiency Is a Risk Factor for Autism
Discover how vitamin D supplementation may reduce Autism Spectrum Disorder symptoms and improve overall functioning in children with ASD.
Reassessing the Safety and Efficacy of Very Low LDL Cholesterol
Though cholesterol-lowering guidance often touts the achievement of very low levels of low-density lipoprotein (LDL) cholesterol, emerging research demonstrates possible…
Highlights From NLA 2025: Early LDL-C Reduction and Emerging Therapies
The 2025 National Lipid Association (NLA) Scientific Sessions highlighted a strategic shift toward early, aggressive cardiometabolic intervention, underscoring the vital…
Steroid Use During ICI Treatment Lessens Effectiveness in Patients With NSCLC
Steroids hindered the shrinkage of tumors in patients with non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitor (ICI) therapy.
Donanemab-Azbt Receives FDA Label Update With New Dosing for Alzheimer Disease
FDA approves a new dosing schedule for donanemab, enhancing safety and efficacy in treating early symptomatic Alzheimer disease.
Community Pneumococcal Vaccination Support Program for Older Adults Reduces Pneumonia-Related Mortality
In a community of older adults, initiating a pneumococcal vaccination support program reduced annual pneumonia-related mortality by 25%, demonstrating broad…